OurPharma Holdings LLC filed an amended Form D with the Securities and Exchange Commission on 2025-07-23.
OurPharma Holdings LLC filed an amended Form D notice of an exempt securities offering with the SEC on July 23, 2025. The filing reports $500K sold. Its industry group is Pharmaceuticals. It names Peter Kohler (Executive Officer, Director), Adam Kohler (Executive Officer, Director), Brooke Erwin (Director) (SEC Form D/A, July 23, 2025).
Is this your company?
Sell to companies like OurPharma Holdings LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns OurPharma Holdings LLC.
Free to see. No signup.
More on the people and the money behind OurPharma Holdings LLC, from the filings we hold.
Other Health Care raises filed within 90 days of this one, largest first.
Get an email when OurPharma Holdings LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when OurPharma Holdings LLC raises, hires or launches. No email unless you switch it on.
Watch OurPharma Holdings LLC →Get the full cited report on OurPharma Holdings LLC
What the filing shows about OurPharma Holdings LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on OurPharma Holdings LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives OurPharma Holdings LLC's address as 2512 S City Lake Rd, Fayetteville, AR 72701.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for OurPharma Holdings LLC →
Amended on 2026-07-10: the amount sold changed from $250,000 to $500,000; the number of investors changed from 1 to 3. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
OurPharma Holdings LLC is a registered filer with the SEC (CIK 1725565) and has filed since 2023-02-24. 4 filings are on record, the latest on 2026-07-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
OurPharma Holdings LLC's Form D of 2025-07-23 names Peter Kohler, Adam Kohler, Brooke Erwin and 3 more as its officers, directors or promoters.
Its new offerings report $250K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Peter Kohler is named as Executive Officer and Director on the Form D that OurPharma Holdings LLC filed with the SEC on 23 July 2025, one of 6 people that filing names.
Adam Kohler is named as Executive Officer and Director on the Form D that OurPharma Holdings LLC filed with the SEC on 23 July 2025, one of 6 people that filing names.
Brooke Erwin is named as Director on the Form D that OurPharma Holdings LLC filed with the SEC on 23 July 2025, one of 6 people that filing names.
Todd Kohler is named as Director on the Form D that OurPharma Holdings LLC filed with the SEC on 23 July 2025, one of 6 people that filing names.
Michael Mauldin is named as Director on the Form D that OurPharma Holdings LLC filed with the SEC on 23 July 2025, one of 6 people that filing names.
Brent Beaulieu is named as Director on the Form D that OurPharma Holdings LLC filed with the SEC on 23 July 2025, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2025-07-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about OurPharma Holdings LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on OurPharma Holdings LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OurPharma Holdings LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist OurPharma Holdings LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind OurPharma Holdings LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for OurPharma Holdings LLC. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ourpharma-holdings-llc-form-d-25000001